Diarrheal illness remains a global concern, particularly impacting children with significant morbidity and mortality rates. Presently, oral rehydration solution (ORS) serves as the standard treatment for acute diarrhea in pediatric cases. While effective in reducing mortality rates, ORS fails to address diarrheal symptoms, leading to reduced compliance and therapeutic effectiveness among caregivers. In a discussion with Moneycontrol's Sonal Mehrotra, Dr Sivaranjani, a pediatrician and social worker, highlighted concerns about FSSAI-approved ORS, noting their high sugar content. Dr Sivaranjani recommended adhering to only WHO-recommended ORS formulations for better health outcomes.
first published: Feb 26, 2024 07:25 pm
A collection of the most-viewed Moneycontrol videos.

Will Nifty Cross 26,100 Hurdle On Weekly F&O Expiry? PhysicsWallah Lists Today|Opening Bell Live

How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple

Nifty Reclaims 26,000; Nifty Bank Hits New Life High| Groww Joins RS 1 Lk Cr Club| Closing Bell Live

Nifty Headed For All-Time Highs After Friday’s Late Recovery?| Opening Bell Live
You are already a Moneycontrol Pro user.

